Yingbio

Yingbio is a Shanghai-based biotechnology company providing research services and products for life science studies. Its work centers on high-throughput second-generation sequencing, supported by bioinformatics analysis and in-house molecular, pathology, and cell experiment platforms. The company offers end-to-end research support, including project design, sequencing, data analysis, experimental testing, and assistance with manuscript preparation and publication.

Yingbio’s services span biochip experiments, high-throughput sequencing, functional mechanism research, animal model development, and primary cell isolation. Featured offerings include CRISPR library screening, Perturb-seq, spatial multi-omics sequencing, and studies of extracellular vesicles. Its product range includes PCR arrays and chips for RNA modifications, ferroptosis, autophagy, and pyroptosis, as well as genetic cancer testing and risk assessments for age-related and cardiovascular or cerebrovascular diseases. Yingbio also provides research solutions involving exosomal RNA and quantitative PCR. Through its service portfolio, the company supports researchers seeking integrated experimental and analytical assistance across a range of biomedical topics.